VSQM
JAZZ icon

V-Square Quantitative Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

V-Square Quantitative Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-680
Closed -$81.9K – 593
2024
Q1 		$81.9K Hold
680
– – 0.01% 545
2023
Q4 		$83.6K Buy
680
+265
+64% +$33.1K 0.01% 545
2023
Q3 		$53.7K Buy
415
+64
+18% +$8.53K 0.02% 494
2023
Q2 		$43.5K Buy
+351
New +$47.2K 0.03% 311

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

V-Square Quantitative Management's JAZZ Position: Q2 2024 in Review

V-Square Quantitative Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 680 shares — an estimated $81.9K sold.

V-Square Quantitative Management first reported a position in JAZZ in Q2 2023 and held it in 4 quarters. The position peaked at $83.6K in Q4 2023. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • V-Square Quantitative Management reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • V-Square Quantitative Management sold 680 Jazz Pharmaceuticals shares in Q2 2024, an estimated $81.9K.
  • V-Square Quantitative Management first reported a position in Jazz Pharmaceuticals in Q2 2023 and held it in 4 quarters.
  • V-Square Quantitative Management's Jazz Pharmaceuticals position peaked at $83.6K in Q4 2023.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on V-Square Quantitative Management's 13F filing for Q2 2024, filed 16 Jul 2024.